C3.AI's Executive Chairman Dumped: What Investors Should Do
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
Conduct a value comparison of no annual fee cash back cards to find the right one for your spending needs. Make informed choices.
25,387 articlesA high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
A Reynolds director recently bought about $99,000 of REYN stock. This article breaks down what reynolds stock directo...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Insider stock moves can tell a story, but one sale isn’t the whole chapter. This guide breaks down what a merit medic...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
Could shiba really turn into a millionaire? This article dives into the chances, math, and practical steps for Approa...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...
Two high-growth names face near-term headwinds. This guide explains why patient investors could benefit from the pull...